{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:19:26Z","timestamp":1786990766732,"version":"build-2736575974"},"reference-count":35,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1016\/j.ijrobp.2013.09.024","type":"journal-article","created":{"date-parts":[[2013,10,22]],"date-time":"2013-10-22T11:30:20Z","timestamp":1382441420000},"page":"57-64","source":"Crossref","is-referenced-by-count":37,"title":["Is Biological Subtype Prognostic of Locoregional Recurrence Risk in Women With pT1-2N0 Breast Cancer Treated With Mastectomy?"],"prefix":"10.1016","volume":"88","author":[{"given":"Pauline T.","family":"Truong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Betro T.","family":"Sadek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria F.","family":"Lesperance","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheryl S.","family":"Alexander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mina","family":"Shenouda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita Abi","family":"Raad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alphonse G.","family":"Taghian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2013.09.024_bib1","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/35021093","article-title":"Molecular portraits of human breast tumours","volume":"406","author":"Perou","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.ijrobp.2013.09.024_bib2","doi-asserted-by":"crossref","first-page":"8418","DOI":"10.1073\/pnas.0932692100","article-title":"Repeated observation of breast tumor subtypes in independent gene expression data sets","volume":"100","author":"Sorlie","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ijrobp.2013.09.024_bib3","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1097\/PDM.0b013e31818d107b","article-title":"Molecular classification of breast carcinomas by immunohistochemical analysis: Are we ready?","volume":"18","author":"Tang","year":"2009","journal-title":"Diagn Mol Pathol"},{"key":"10.1016\/j.ijrobp.2013.09.024_bib4","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1200\/JCO.2007.14.4287","article-title":"Breast cancer subtype approximated by estrogen receptor, progesterone receptor, and HER-2 is associated with local and distant recurrence after breast conserving therapy","volume":"26","author":"Nguyen","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2013.09.024_bib5","doi-asserted-by":"crossref","first-page":"3885","DOI":"10.1200\/JCO.2011.36.1105","article-title":"Age, breast cancer subtype approximation, and local recurrence after breast-conserving therapy","volume":"29","author":"Arvold","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2013.09.024_bib6","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1016\/S0140-6736(05)67887-7","article-title":"Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: An overview of the randomised trials","volume":"366","author":"Clarke","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.ijrobp.2013.09.024_bib7","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1093\/annonc\/mdp322","article-title":"Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2009","volume":"20","author":"Goldhirsch","year":"2009","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ijrobp.2013.09.024_bib8","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.radonc.2008.04.014","article-title":"High local recurrence risk is not associated with large survival reduction after postmastectomy radiotherapy in high-risk breast cancer: A subgroup analysis of DBCG 82 b&c","volume":"90","author":"Kyndi","year":"2009","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2013.09.024_bib9","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1002\/cncr.11188","article-title":"Ki-67 expression in breast carcinoma: Its association with grading systems, clinical parameters, and other prognostic factors\u2014a surrogate marker?","volume":"97","author":"Trihia","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2013.09.024_bib10","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1093\/annonc\/mdr304","article-title":"Strategies for subtypes: dealing with the diversity of breast cancer: Highlights of the St Gallen International Expert Consensus on the primary therapy of early breast cancer 2011","volume":"22","author":"Goldhirsch","year":"2011","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ijrobp.2013.09.024_bib11","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1056\/NEJMoa052306","article-title":"Trastuzumab after adjuvant chemotherapy in HER-2-positive breast cancer","volume":"353","author":"Piccart-Gebhart","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijrobp.2013.09.024_bib12","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1056\/NEJMoa052122","article-title":"Trastuzumab plus adjuvant chemotherapy for operable HER-2-positive breast cancer","volume":"353","author":"Romond","year":"2005","journal-title":"N Engl J\u00a0Med"},{"key":"10.1016\/j.ijrobp.2013.09.024_bib13","doi-asserted-by":"crossref","first-page":"5652","DOI":"10.1200\/JCO.2006.06.5664","article-title":"Locoregional relapse and distant metastasis in conservatively managed triple negative early-stage breast cancer","volume":"24","author":"Haffty","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2013.09.024_bib14","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1002\/cncr.24094","article-title":"Locoregional recurrence of triple-negative breast cancer after breast-conserving surgery and radiation","volume":"115","author":"Freedman","year":"2009","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2013.09.024_bib15","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/j.ijrobp.2012.02.047","article-title":"Prognostic value of molecular subtypes, Ki67 expression, and impact of postmastectomy radiation therapy in breast cancer patients with negative lymph nodes after mastectomy","volume":"84","author":"Selz","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2013.09.024_bib16","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1007\/s00268-011-1240-2","article-title":"Prognostic factors affecting postmastectomy locoregional recurrence in patients with early breast cancer: Are intrinsic subtypes effective?","volume":"35","author":"Mersin","year":"2011","journal-title":"World J Surg"},{"key":"10.1016\/j.ijrobp.2013.09.024_bib17","doi-asserted-by":"crossref","first-page":"R32","DOI":"10.1186\/bcr3197","article-title":"Implications of constructed biologic subtype and its relationship to locoregional recurrence following mastectomy","volume":"14","author":"Dominici","year":"2012","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.ijrobp.2013.09.024_bib18","doi-asserted-by":"crossref","first-page":"4429","DOI":"10.1158\/1078-0432.CCR-06-3045","article-title":"Triple-negative breast cancer: Clinical features and patterns of recurrence","volume":"13","author":"Dent","year":"2007","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ijrobp.2013.09.024_bib19","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1007\/s10549-011-1495-1","article-title":"Risk of locoregional recurrence by receptor status in breast cancer patients receiving modern systemic therapy and post-mastectomy radiation","volume":"128","author":"Panoff","year":"2011","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.ijrobp.2013.09.024_bib20","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s10549-010-1135-1","article-title":"The association between biological subtype and locoregional recurrence in newly diagnosed breast cancer","volume":"124","author":"Gabos","year":"2010","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.ijrobp.2013.09.024_bib21","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1200\/JCO.2009.24.9284","article-title":"Breast cancer subtypes and the risk of local and regional relapse","volume":"28","author":"Voduc","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2013.09.024_bib22","doi-asserted-by":"crossref","first-page":"2852","DOI":"10.1200\/JCO.2010.33.4714","article-title":"Increased risk of locoregional recurrence for women with T1-2N0 triple-negative breast cancer treated with modified radical mastectomy without adjuvant radiation therapy compared with breast-conserving therapy","volume":"29","author":"Abdulkarim","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2013.09.024_bib23","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1002\/cncr.28085","article-title":"Analysis in early stage triple-negative breast cancer treated with mastectomy without adjuvant radiotherapy: Patterns of failure and prognostic factors","volume":"119","author":"Chen","year":"2013","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2013.09.024_bib24","doi-asserted-by":"crossref","first-page":"4944","DOI":"10.1002\/cncr.27480","article-title":"Favorable prognosis in patients with T1a\/T1bN0 triple-negative breast cancers treated with multimodality therapy","volume":"118","author":"Ho","year":"2012","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2013.09.024_bib25","doi-asserted-by":"crossref","first-page":"3469","DOI":"10.1245\/s10434-013-3011-9","article-title":"Breast-conserving therapy achieves locoregional outcomes comparable to mastectomy in women with T1-2N0 triple-negative breast cancer","volume":"20","author":"Zumsteg","year":"2013","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ijrobp.2013.09.024_bib26","doi-asserted-by":"crossref","first-page":"3164","DOI":"10.1245\/s10434-011-1920-z","article-title":"Triple-negative breast cancer is not a contraindication for breast conservation","volume":"18","author":"Adkins","year":"2011","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ijrobp.2013.09.024_bib27","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.ijrobp.2004.09.013","article-title":"Patient subsets with T1-2, node-negative breast cancer at high locoregional recurrence risks after mastectomy","volume":"62","author":"Truong","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2013.09.024_bib28","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/j.ijrobp.2004.12.014","article-title":"Locoregional recurrence rates\u00a0and prognostic factors for failure in node-negative patients treated with mastectomy: Implications for postmastectomy radiation","volume":"62","author":"Jagsi","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2013.09.024_bib29","doi-asserted-by":"crossref","first-page":"e151","DOI":"10.1016\/j.ijrobp.2011.01.015","article-title":"Patterns and risk factors of locoregional recurrence in T1-T2 node negative breast cancer patients\u00a0treated with mastectomy: Implications for postmastectomy radiotherapy","volume":"81","author":"Abi-Raad","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2013.09.024_bib30","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/j.ijrobp.2007.01.015","article-title":"Can a subgroup of node-negative breast carcinoma patients with T1-2 tumor who may benefit from postmastectomy radiotherapy be identified?","volume":"68","author":"Yildirim","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2013.09.024_bib31","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1016\/j.ijrobp.2009.12.011","article-title":"Estrogen\/progesterone receptor negativity and Her2 positivity predict locoregional recurrence in patients with pT1a, bN0 breast cancer","volume":"77","author":"Albert","year":"2010","journal-title":"Int\u00a0J\u00a0Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2013.09.024_bib32","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/j.ijrobp.2012.02.048","article-title":"Surgical margins and the risk of local-regional recurrence after mastectomy without radiation therapy","volume":"84","author":"Childs","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2013.09.024_bib33","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.radonc.2011.07.007","article-title":"Adjuvant chemotherapy and radiotherapy in triple-negative breast carcinoma: A prospective randomized controlled multi-center trial","volume":"100","author":"Wang","year":"2011","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2013.09.024_bib34","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1634\/theoncologist.2012-0397","article-title":"Molecular characterization of basal-like and non-basal-like triple-negative breast cancer","volume":"18","author":"Prat","year":"2013","journal-title":"Oncologist"},{"key":"10.1016\/j.ijrobp.2013.09.024_bib35","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1200\/JCO.2009.27.1080","article-title":"Molecular predictors of locoregional recurrence in breast cancer: Ready for prime time?","volume":"28","author":"Haffty","year":"2010","journal-title":"J Clin Oncol"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301613031118?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301613031118?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,11]],"date-time":"2018-10-11T18:54:25Z","timestamp":1539284065000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301613031118"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,1]]}},"alternative-id":["S0360301613031118"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2013.09.024","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2014,1]]}}}